Switch to:
More From Other Websites
Final Glance: Pharmaceuticals companies Mar 27 2015
Gilead's Hepatitis C Drug Sovaldi Gets Approval in Japan - Analyst Blog Mar 27 2015
Immune Design Starts Dosing Patients in CMB305 Study - Analyst Blog Mar 27 2015
Midday Glance: Pharmaceuticals companies Mar 27 2015
Europe pushes back verdict on Bristol immune system cancer drug Mar 27 2015
Europe pushes back verdict on Bristol immune system cancer drug Mar 27 2015
Bristol-Myers Squibb to Announce Results for First Quarter 2015 on April 28 Mar 27 2015
Bristol-Myers Squibb to Announce Results for First Quarter 2015 on April 28 Mar 27 2015
Healthcare Hedge Fund Orbimed’s Top Picks and New Move Mar 26 2015
Early Glance: Pharmaceuticals companies Mar 26 2015
Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog Mar 26 2015
Good time for investors to jump in: Pro Mar 25 2015
Science, patients driving rare disease drug research surge Mar 25 2015
Hottest dividend stocks of 2015 Mar 24 2015
Bristol-Myers Squibb (BMY) Stock Price Target Increased at BMO Mar 24 2015
Bristol-Myers in Autoimmune Program Deal Mar 24 2015
Bristol-Myers buys rights to Novo Nordisk immune system project Mar 24 2015
Bristol-Myers Squibb Acquires Exclusive License from Novo Nordisk for a Discovery Research Program... Mar 24 2015
Bristol-Myers Squibb Acquires Exclusive License from Novo Nordisk for a Discovery Research Program... Mar 24 2015
Bristol, Sanofi and Novartis drugs to shine among 2015 launches Mar 23 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK